Last updated on July 2019

Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With Schizophrenia


Brief description of study

To determine the safety & efficacy of brexpiprazole monotherapy in the treatment of adolescents with schizophrenia.

Detailed Study Description

This is a multicenter, randomized, double-blind, placebo- and active-controlled trial to evaluate the safety and efficacy of brexpiprazole monotherapy compared to placebo in adolescent subjects (ages 13-17) with a DSM-5 diagnosis of schizophrenia.

Clinical Study Identifier: NCT03198078

Find a site near you

Start Over

CMB Clinical Trials LLC

Colton, CA United States
  Connect »

ProScience Research Group

Culver City, CA United States
  Connect »

CITrials

Riverside, CA United States
  Connect »

Institute of Living

Hartford, CT United States
  Connect »

Lake Charles Clinical Trials

Lake Charles, LA United States
  Connect »

Kolade Research Institute

Las Vegas, NV United States
  Connect »

Finger Lakes Clinical Research

Rochester, NY United States
  Connect »

New Hope Clinical Research

Charlotte, NC United States
  Connect »

Berma Research Group

Kinston, NC United States
  Connect »

Charak Clinical Research Center

Garfield Heights, OH United States
  Connect »

CincyScience

West Chester, OH United States
  Connect »

Red River Medical Research Center

Oklahoma City, OK United States
  Connect »

Cutting Edge Research Group

Oklahoma City, OK United States
  Connect »

Premier Clinical Research

Spokane, WA United States
  Connect »